Hamlin Capital Management, LLC Abb Vie Inc. Transaction History

Hamlin Capital Management, LLC

$3.97 Billion
Q3 2024

A detailed history of Hamlin Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hamlin Capital Management, LLC holds 1,024,031 shares of ABBV stock, worth $179 Million. This represents 5.09% of its overall portfolio holdings.

Number of Shares

1,024,031

Previous 947,813 8.04%

Holding current value

$179 Million

Previous $163 Million 24.39%

% of portfolio

5.09%

Previous 4.79%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $12.5 Million - $15.2 Million	76,218 Added 8.04%	1,024,031 $202 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $344,562 - $402,371	-2,226 Reduced 0.23%	947,813 $163 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.06 Million - $1.21 Million	-6,658 Reduced 0.7%	950,039 $173 Million
Q4 2023 Jan 09, 2024	SELL	$137.6 - $154.97 $643,004 - $724,174	-4,673 Reduced 0.49%	956,697 $148 Million
Q3 2023 Oct 04, 2023	BUY	$133.59 - $154.65 $1.24 Million - $1.43 Million	9,251 Added 0.97%	961,370 $143 Million
Q2 2023 Jul 14, 2023	BUY	$132.51 - $164.9 $237,325 - $295,335	1,791 Added 0.19%	952,119 $128 Million
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $2.79 Million - $3.21 Million	-19,302 Reduced 1.99%	950,328 $151 Million
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $3.09 Million - $3.71 Million	22,373 Added 2.36%	969,630 $0
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $10,334 - $11,852	77 Added 0.01%	947,257 $127 Million
Q2 2022 Jul 12, 2022	BUY	$137.62 - $174.96 $1.87 Million - $2.38 Million	13,613 Added 1.46%	947,180 $145 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $1.59 Million - $1.97 Million	-12,022 Reduced 1.27%	933,567 $151 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $1.1 Million - $1.39 Million	10,245 Added 1.1%	945,589 $128 Million
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $135,660 - $153,994	-1,275 Reduced 0.14%	935,344 $101 Million
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $4.12 Million - $4.59 Million	39,155 Added 4.36%	936,619 $106 Million
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $546,588 - $601,728	5,343 Added 0.6%	897,464 $97.1 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $2.27 Million - $3.07 Million	28,253 Added 3.27%	892,121 $95.6 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $15.2 Million - $17.9 Million	177,344 Added 25.83%	863,868 $75.7 Million
Q2 2020 Jul 15, 2020	SELL	$73.37 - $98.18 $13.8 Million - $18.5 Million	-188,032 Reduced 21.5%	686,524 $67.4 Million
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $5.44 Million - $8.25 Million	-84,328 Reduced 8.79%	874,556 $66.6 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $448,215 - $560,813	-6,214 Reduced 0.64%	958,884 $84.9 Million
Q3 2019 Oct 16, 2019	BUY	$62.98 - $75.72 $9.89 Million - $11.9 Million	156,975 Added 19.42%	965,098 $73.1 Million
Q2 2019 Jul 22, 2019	BUY	$65.7 - $83.98 $6.69 Million - $8.56 Million	101,883 Added 14.43%	808,123 $58.8 Million
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $1.58 Million - $1.86 Million	-20,465 Reduced 2.82%	706,240 $56.9 Million
Q4 2018 Jan 18, 2019	BUY	$77.85 - $96.01 $698,781 - $861,785	8,976 Added 1.25%	726,705 $67 Million
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $11.7 Million - $13 Million	131,581 Added 22.45%	717,729 $67.9 Million
Q2 2018 Jul 12, 2018	SELL	$89.78 - $106.23 $1.77 Million - $2.09 Million	-19,665 Reduced 3.25%	586,148 $54.3 Million
Q1 2018 Apr 18, 2018	SELL	$92.01 - $123.21 $55.7 Million - $74.6 Million	-605,813 Reduced 50.0%	605,813 $57.3 Million
Q1 2018 Apr 16, 2018	BUY	$92.01 - $123.21 $40.1 Million - $53.6 Million	435,315 Added 56.07%	1,211,626 $115 Million
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $2.32 Million - $2.54 Million	-25,904 Reduced 3.23%	776,311 $75.1 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $56 Million - $71.6 Million	802,215	802,215 $71.3 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamlin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamlin Capital Management, LLC with notifications on news.

Account

Hamlin Capital Management, LLC Abb Vie Inc. Transaction History